Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT00071058
Status:
COMPLETED
Last Update Posted:
2012-09-18
First Post:
2003-10-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-09
First Submit QC Date:
None
Study First Post Date:
2003-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-13
Results First Submit QC Date:
None
Results First Post Date:
2012-09-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-12
Last Update Post Date:
2012-09-18
Last Update Post Date Type:
ESTIMATED